Promethazine (Phenergan) IM Dosing and Site
For intramuscular administration, promethazine should be given as a deep IM injection at a dose of 12.5-25 mg, with a total dose range of 25-100 mg when used as an adjuvant to narcotics and benzodiazepines. 1, 2, 3
Dosing Guidelines
Standard IM Dose:
- 12.5-25 mg is the usual starting dose 1, 2, 1
- Total dose may range from 25-100 mg when used as adjuvant therapy 1
- For pediatric patients ≥2 years: 0.5 mg/kg (maximum varies by indication) 4
The FDA label explicitly states that deep intramuscular use is preferred over intravenous administration due to safety concerns 3.
Injection Site
The preferred site is deep intramuscular injection into a large muscle mass. While the specific anatomical site is not explicitly stated in the guidelines, standard IM injection principles apply:
- Deltoid muscle (arm) for adults
- Vastus lateralis (anterolateral thigh) as an alternative large muscle site
- Ventrogluteal or dorsogluteal sites for larger volumes
The evidence from endoscopy studies documents successful use of 25-100 mg IM without hypotension or respiratory failure when administered properly 1.
Critical Safety Considerations
Avoid subcutaneous or intra-arterial injection at all costs - these routes are contraindicated and can cause severe tissue injury, gangrene, and may require amputation 2, 3, 5, 6. The FDA added a black box warning specifically addressing this risk 3.
Age restrictions:
- Contraindicated in children <2 years due to fatal respiratory depression risk 3
- Use lowest effective dose in children ≥2 years 3
Respiratory precautions:
- Avoid in patients with compromised respiratory function (COPD, sleep apnea) 3
- Risk of respiratory depression increases when combined with other CNS depressants 1, 2, 3
- May require reduction in dosage of concurrent sedation agents 1, 2
Pharmacokinetics
- Onset: Clinical effects evident within 5 minutes 1, 2, 1
- Duration: 4-6 hours 1, 2, 1
- Half-life: 9-16 hours 1, 2, 1
Common Adverse Effects
Monitor for hypotension, respiratory depression, extrapyramidal effects (restlessness to oculogyric crises), and neuroleptic malignant syndrome 1, 2, 3. Sedation is expected and may impair performance significantly - one study showed performance decrements equivalent to blood alcohol levels of 0.085% at 25 mg dose 7.
Clinical Context
Promethazine IM has been successfully used in endoscopic procedures (25-100 mg with meperidine) with completion of procedures and no episodes of hypotension when given properly 1. However, recent safety initiatives from ISMP and ASHP advocate for removing injectable promethazine from formularies entirely due to tissue injury risks 6.